| MicroRNAs 15A and 16–1 activate signaling pathways that mediate chemotaxis of immune regulatory B cells to colorectal tumors R Liu, Z Lu, J Gu, J Liu, E Huang, X Liu, L Wang, J Yang, Y Deng, J Qian, ... Gastroenterology 154 (3), 637-651. e7, 2018 | 106 | 2018 |
| Reactive oxygen species: the signal regulator of B cell H Zhang, L Wang, Y Chu Free Radical Biology and Medicine 142, 16-22, 2019 | 48 | 2019 |
| The potential use of dynamics changes of ctDNA and cfDNA in the perioperative period to predict the recurrence risk in early NSCLC X Zhao, F Dai, L Mei, D Huang, X Shen, H Zhang, X She, Z Ma Frontiers in Oncology 11, 671963, 2021 | 29 | 2021 |
| Reactive oxygen species stimulated pulmonary epithelial cells mediate the alveolar recruitment of FasL+ killer B cells in LPS-induced acute lung injuries H Zhang, Z Wang, R Liu, T Qian, J Liu, L Wang, Y Chu Journal of Leukocyte Biology 104 (6), 1187-1198, 2018 | 24 | 2018 |
| Peyer's patches‐derived CD11b+ B cells recruit regulatory T cells through CXCL9 in dextran sulphate sodium‐induced colitis Z Wang, H Zhang, R Liu, T Qian, J Liu, E Huang, Z Lu, C Zhao, L Wang, ... Immunology 155 (3), 356-366, 2018 | 24 | 2018 |
| Deceleration of glycometabolism impedes IgG‐producing B‐cell‐mediated tumor elimination by targeting SATB 1 J Liu, Y Li, Z Lu, J Gu, Y Liang, E Huang, Z Wang, H Zhang, L Wang, ... Immunology 156 (1), 56-68, 2019 | 18 | 2019 |
| The prospect of immunotherapy combined with chemotherapy in patients with advanced non-small cell lung cancer: a narrative review X Ning, Y Yu, S Shao, R Deng, J Yu, X Wang, X She, D Huang, X Shen, ... Annals of Translational Medicine 9 (22), 2021 | 17 | 2021 |
| Various subtypes of EGFR mutations in patients with NSCLC define genetic, immunologic diversity and possess different prognostic biomarkers Y Lei, K Wang, Y Liu, X Wang, X Xiang, X Ning, W Ding, J Duan, D Li, ... Frontiers in Immunology 13, 811601, 2022 | 14 | 2022 |
| MDM2: current research status and prospects of tumor treatment Y Yao, Q Zhang, Z Li, H Zhang Cancer Cell International 24 (1), 170, 2024 | 13 | 2024 |
| Immune microenvironment: new insight for familial adenomatous polyposis J Yang, Z Wen, W Li, X Sun, J Ma, X She, H Zhang, C Tu, G Wang, ... Frontiers in oncology 11, 570241, 2021 | 10 | 2021 |
| Immunotherapy and potential predictive biomarkers in the treatment of neuroendocrine neoplasia G Xu, Y Wang, H Zhang, X She, J Yang Future Oncology 17 (9), 1069-1081, 2021 | 9 | 2021 |
| Case Report: RAB10-ALK: A Novel ALK Fusion in a Patient With Gastric Cancer Z Wen, D Xiong, S Zhang, J Liu, B Li, R Li, H Zhang Frontiers in oncology 11, 645370, 2021 | 9 | 2021 |
| M1 macrophage predicted efficacy of neoadjuvant camrelizumab combined with chemotherapy vs chemotherapy alone for locally advanced ESCC: A pilot study S Wang, G Xu, M Li, J Zheng, Y Wang, X Feng, J Luo, S Wang, H Liu, ... Frontiers in Oncology 13, 1139990, 2023 | 8 | 2023 |
| The potentiality of immunotherapy for sarcomas: a summary of potential predictive biomarkers J Liang, D Chen, L Chen, X She, H Zhang, Y Xiao Future Oncology 16 (17), 1211-1223, 2020 | 5 | 2020 |
| Landscape of RB1 alterations in 22,432 Chinese solid tumor patients G Xu, J Zheng, S Wang, Y Wang, G Li, N Wang, X She, W Duan, H Zhang, ... Annals of translational medicine 10 (16), 2022 | 3 | 2022 |
| Genetic profile of Chinese patients with small bowel cancer categorized by anatomic location C Shi, J Ma, T Zhang, Y Shi, W Duan, D Huang, H Zhang, Y Zeng BMC Medical Genomics 16 (1), 289, 2023 | 2 | 2023 |
| Variation of the ileocolic artery and superior mesenteric artery in a patient with right-sided colon cancer with Lynch syndrome: a case report K Du, J Ren, G Zheng, S Li, L Chen, W Hou, W Duan, D Huang, H Zhang, ... Annals of Translational Medicine 10 (17), 2022 | 2 | 2022 |
| Case report: Response to almonertinib in a patient with metastatic NSCLC resistant to osimertinib due to acquired EGFR L718Q Mutation G Shen, L Shi, X Tian, D Huang, H Chen, C Gao, X Shen, H Zhang Frontiers in Pharmacology 12, 731895, 2021 | 2 | 2021 |
| Comparison of molecular profiling between Chinese cholangiocarcinoma and gallbladder cancer through next-generation sequencing C Yu, H Zhang, J Luo, S Zhao Cancer Research 81 (13_Supplement), 2194-2194, 2021 | 2 | 2021 |
| Uncommon EGFR mutations are associated with higher tumor mutation burden (TMB) in non-small cell lung cancer patients X Shen, H Zhang, D Huang Cancer Research 80 (16_Supplement), 824-824, 2020 | 2 | 2020 |
Xueke SheMoffitt Cancer Center在 moffitt.org 的电子邮件经过验证
